Treatment of secondary tonsillar herniation by lumboperitoneal shunt revision

Canadian Journal of Neurological Sciences

Volumn 34, Issue 2, 2007, Pages 237-242

  Lam, Fred C ^a   Wheatley, Matthew B ^a   Mehta, Vivek ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; FUROSEMIDE; STEROID;

ADULT; ARTICLE; BRAIN VENTRICLE; CASE REPORT; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT; CLINICAL FEATURE; DECOMPRESSION SURGERY; DRUG WITHDRAWAL; FEMALE; FORAMEN MAGNUM; HERNIA; HUMAN; INTRACRANIAL HYPERTENSION; LUMBOPERITONEAL SHUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR FOSSA; PRIORITY JOURNAL; SHUNTING; TONSILLAR HERNIATION; TREATMENT OUTCOME;

EID: 34347209849     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100006119     Document Type: Article

References (33)

1. Quincke H. Uber meningitis serosa: Sammlung linische Vortra 67. Inn Med. 1893;23:655-94.
2. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumour cerebri: population studies in Iowa and Louisiana. Arch Neurol. 1988;45:875-7.
3. Dandy WE. Intracranial pressure without brain tumour: diagnosis and treatment. Ann Surg. 1937;106:492-513.
4. Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Arch Neurol. 1989;46:1049-51.
5. Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuro-Ophthalmol. 2004;24:138-45.
6. Newborg B. Pseudotumour cerebri treated by rice/reduction diet. Arch Intern Med. 1974;133:802-7.
7. Binder DK, Horton JC, Lawton MT, McDermott MW. Idiopathic intracranial hypertension. Neurosurgery. 2004;54:538-52.
8. Physician's Desk Reference, 56th ed. Montvale, NJ: Medical Economics Company, Inc; 2002: 2590-5.
9. Lui GT, Glaser JS, Schatz NJ. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumour cerebri. Am J Ophthalmol. 1994;118:88-96.
10. King JO, Mitchell PJ, Thomson KR, Tress BM. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology. 2002;58:26-30.
11. Carter S, Seiff SR. Macular changes in pseudotumour cerebri before and after optic nerve sheath fenestration. Ophthalmology. 1995;102:937-41.
12. Keltner JL. Optic nerve sheath decompression. How does it work? Has its time come? Arch Ophthalmol. 1988;106:1365-9.
13. Rosenberg ML, Corbett JJ, Smith C, Goodwin J, Sergott R, Savino P, et al. Cerebrospinal fluid diversion procedures in pseudotumour cerebri. Neurology. 1993;43:1071-2.
14. Alleyne CH Jr, Shutter LA, Colohan AR. Cranial migration of a lumboperitoneal shunt catheter. So Med J. 1996;89:634-6.
15. Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumour cerebri. Neurology. 1996;46:1524-30.
16. Chumas PD, Armstrong DC, Drake JM, Kulkarni AV, Hoffman HJ, Humphreys RP, et al. Tonsillar herniaton: the rule rather than the exception after lumboperitoneal shunting in the pediatric population. J Neurosurg. 1993;78:568-73.
17. Johnston I, Jacobson E, Besser M. The acquired Chiari malformation and syringomyelia following spinal CSF drainage. Acta Neurochir. 1998;140:417-28.
18. Horton JC, Fishman RA. Neurovisual findings in the syndrome of spontaneous intracranial hypotension from dural cerebrospinal fluid leak. Ophthalmology. 1994;101:244-51.
19. Mokri B. Spontaneous cerebrospinal fluid leaks: from intracranial hypotension to cerebrospinal fluid hypovolemia - evolution of a concept. Mayo Clinic Proc. 1999;74:1113-23.
20. Pannullo SC, Reich JB, Krol G, Deck MD, Posner JB. MRI changes in intracranial hypotension. Neurology. 1993;43:919-26.
21. Black PM, Hakim R, Bailey N. The use of the Codman-Medos programmable Hakim valve in the management of patients with hydrocephalus: illustrative cases. Neurosurgery. 1994;34:1110-2.
22. Zemack O, Romner B. Do adjustable shunt valves pressure our budget? A retrospective analysis of 541 implanted Codman Hakim programmable valves. Brit J Neurosurg. 2001;15: 221-7.
23. Mangano FT, Menendez JA, Habrock T, Narayan P, Leonard JR, Park TS, et al. Early programmable valve malfunctions in pediatric hydrocephalus. J Neurosurg (6 Suppl Pediatr). 2005;103:501-7.
24. Payner TD, Prenger E, Berger TS, Crone KR. Acquired Chiari malformations: incidence, diagnosis, and management. Neurosurgery. 1994;34:429-34.
25. Sullivan LP, Stears JC, Ringel SP. Resolution of syringomyelia and Chiari I malformation by ventriculoatrial shunting in a patient with pseudotumour cerebri and a lumboperitoneal shunt. Neurosurgery. 1988;22:744-7.
26. Welch K, Shillito J, Strand R, Fischer EG, Winston KR. Chiari I "malformation" - an acquired disorder? J Neurosurg. 1981;55:604-9.
27. Hart A, David K, Powell M. The treatment of 'acquired tonsillar herniation' in pseudotumor cerebri. Br J Neurosurg 2000;14:563-65.
28. Hoffman HJ, Tucker WS. Cephalocranial disproportion: a complication of the treatment of hydrocephalus in children. Childs Brain. 1976;2:167-76.
29. Levine DN. The pathogenesis of syringomyelia associated with lesions at the foramen magnum: a critical review of existing theories and proposal of a new hypothesis. J Neurol Sci. 2004;220:3-21.
30. Willams B. The distending force in the production of 'communicating syringomyelia'. Lancet. 1969;4:189-93.
31. Chumas PD, Kulkarni AV, Drake JM, Hoffman HJ, Humphreys RP, Rutka JT. Lumboperitoneal shunting: a retrospective study in the paediatric population. Neurosurgery. 1993;32:376-83.
32. Fischer EG, Welch K, Shilito J. Syringomyelia following lumboureteral shunting. J Neurosurg. 1977;47:96-100.
33. Padmanabhan R, Crompton D, Burn D, Birchall D. Acquired Chiari I malformation and syringomyelia following lumboperitoneal shunting for pseudotumour cerebri. J Neurol Neurosurg Psych. 2005;76:298.